Cargando…

Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma

BACKGROUND: Extrachromosomal circular DNAs (eccDNAs) increase the number of proto‐oncogenes by enhancing oncogene expression to promote tumorigenesis. However, there are limited reports on differential eccDNA expression and analysis in lung cancer, especially in lung adenocarcinoma (LAD). METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Gang, Shi, Wenjing, Ling, Liqun, Li, Changhong, Shao, Fanggui, Chen, Jie, Wang, Yumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169211/
https://www.ncbi.nlm.nih.gov/pubmed/35441736
http://dx.doi.org/10.1002/jcla.24425
_version_ 1784721160574861312
author Xu, Gang
Shi, Wenjing
Ling, Liqun
Li, Changhong
Shao, Fanggui
Chen, Jie
Wang, Yumin
author_facet Xu, Gang
Shi, Wenjing
Ling, Liqun
Li, Changhong
Shao, Fanggui
Chen, Jie
Wang, Yumin
author_sort Xu, Gang
collection PubMed
description BACKGROUND: Extrachromosomal circular DNAs (eccDNAs) increase the number of proto‐oncogenes by enhancing oncogene expression to promote tumorigenesis. However, there are limited reports on differential eccDNA expression and analysis in lung cancer, especially in lung adenocarcinoma (LAD). METHODS: Three LAD and three corresponding NT tissues samples were used for eccDNA next‐generation sequencing analysis, and an additional 20 were used for quantitative PCR (qPCR) evaluations. We further performed qPCR amplification using serum samples from LAD patients and healthy medical examiners. RESULTS: eccDNAs from LAD samples were mainly 200–1000 bp in length. Gene annotation analysis revealed that most eccDNAs were derived from chromosomes 1 and 2. The top‐ten increased and top‐ten decreased eccDNAs in LAD tissues were CircD‐ARPC1B, CircD‐ARPC1A, CircD‐FAM49B, CircD‐SDK1, CircD‐KCNG1, CircD‐POLR2F, CircD‐SS18L1, CircD‐SLC16A3, CircD‐CSNK1D, CircD‐KCTD1, and CircD‐TMIGD2, CircD‐PDIA5, CircD‐VAV2, CircD‐GATAD2A, CircD‐CAB39L, CircD‐KHDC1, CircD‐FOXN3, CircD‐SULT2B1, CircD‐DPP9, and CircD‐CSNK1D. qPCR demonstrated that the expression of CircD‐DZRN3 was higher in LAD tissues than in normal lung tissues, whereas CircD‐LGR6 and CircD‐UMODL1 expression levels were lower in LAD than in normal lung tissues. Furthermore, the serum CircD‐PDZRN3 level increased, while CircD‐LGR6 decreased in LAD. Receiver operating characteristic (ROC) analysis showed that area under curve (AUC) of serum CircD‐PDZRN3 (0.991), CircD‐LGR6 (0.916) was higher than that of serum carcinoembryonic antigen (CEA) (0.825), CY211 (cytokeratin 19 fragment) (0.842), SCCA(squamous cell carcinoma antigen) (0.857) for the diagnosis of LAD. CONCLUSIONS: Our study first showed that several eccDNAs were aberrantly expressed in LAD, among which CircD‐PDZRN3 and CircD‐LGR6 clearly distinguished LAD patients from healthy controls, indicating their potential as biomarkers.
format Online
Article
Text
id pubmed-9169211
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91692112022-06-07 Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma Xu, Gang Shi, Wenjing Ling, Liqun Li, Changhong Shao, Fanggui Chen, Jie Wang, Yumin J Clin Lab Anal Research Articles BACKGROUND: Extrachromosomal circular DNAs (eccDNAs) increase the number of proto‐oncogenes by enhancing oncogene expression to promote tumorigenesis. However, there are limited reports on differential eccDNA expression and analysis in lung cancer, especially in lung adenocarcinoma (LAD). METHODS: Three LAD and three corresponding NT tissues samples were used for eccDNA next‐generation sequencing analysis, and an additional 20 were used for quantitative PCR (qPCR) evaluations. We further performed qPCR amplification using serum samples from LAD patients and healthy medical examiners. RESULTS: eccDNAs from LAD samples were mainly 200–1000 bp in length. Gene annotation analysis revealed that most eccDNAs were derived from chromosomes 1 and 2. The top‐ten increased and top‐ten decreased eccDNAs in LAD tissues were CircD‐ARPC1B, CircD‐ARPC1A, CircD‐FAM49B, CircD‐SDK1, CircD‐KCNG1, CircD‐POLR2F, CircD‐SS18L1, CircD‐SLC16A3, CircD‐CSNK1D, CircD‐KCTD1, and CircD‐TMIGD2, CircD‐PDIA5, CircD‐VAV2, CircD‐GATAD2A, CircD‐CAB39L, CircD‐KHDC1, CircD‐FOXN3, CircD‐SULT2B1, CircD‐DPP9, and CircD‐CSNK1D. qPCR demonstrated that the expression of CircD‐DZRN3 was higher in LAD tissues than in normal lung tissues, whereas CircD‐LGR6 and CircD‐UMODL1 expression levels were lower in LAD than in normal lung tissues. Furthermore, the serum CircD‐PDZRN3 level increased, while CircD‐LGR6 decreased in LAD. Receiver operating characteristic (ROC) analysis showed that area under curve (AUC) of serum CircD‐PDZRN3 (0.991), CircD‐LGR6 (0.916) was higher than that of serum carcinoembryonic antigen (CEA) (0.825), CY211 (cytokeratin 19 fragment) (0.842), SCCA(squamous cell carcinoma antigen) (0.857) for the diagnosis of LAD. CONCLUSIONS: Our study first showed that several eccDNAs were aberrantly expressed in LAD, among which CircD‐PDZRN3 and CircD‐LGR6 clearly distinguished LAD patients from healthy controls, indicating their potential as biomarkers. John Wiley and Sons Inc. 2022-04-20 /pmc/articles/PMC9169211/ /pubmed/35441736 http://dx.doi.org/10.1002/jcla.24425 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Xu, Gang
Shi, Wenjing
Ling, Liqun
Li, Changhong
Shao, Fanggui
Chen, Jie
Wang, Yumin
Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma
title Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma
title_full Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma
title_fullStr Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma
title_full_unstemmed Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma
title_short Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in lung adenocarcinoma
title_sort differential expression and analysis of extrachromosomal circular dnas as serum biomarkers in lung adenocarcinoma
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169211/
https://www.ncbi.nlm.nih.gov/pubmed/35441736
http://dx.doi.org/10.1002/jcla.24425
work_keys_str_mv AT xugang differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma
AT shiwenjing differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma
AT lingliqun differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma
AT lichanghong differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma
AT shaofanggui differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma
AT chenjie differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma
AT wangyumin differentialexpressionandanalysisofextrachromosomalcirculardnasasserumbiomarkersinlungadenocarcinoma